nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2C9—brain cancer	0.576	1	CbGaD
Amprenavir—ABCC1—Etoposide—brain cancer	0.0698	0.197	CbGbCtD
Amprenavir—CYP2D6—Lomustine—brain cancer	0.0656	0.186	CbGbCtD
Amprenavir—CYP2D6—Hydroxyurea—brain cancer	0.0498	0.141	CbGbCtD
Amprenavir—CYP3A4—Temozolomide—brain cancer	0.0491	0.139	CbGbCtD
Amprenavir—CYP3A4—Lomustine—brain cancer	0.0417	0.118	CbGbCtD
Amprenavir—CYP3A5—Etoposide—brain cancer	0.0259	0.0731	CbGbCtD
Amprenavir—CYP2C8—Etoposide—brain cancer	0.0249	0.0703	CbGbCtD
Amprenavir—ABCB1—Etoposide—brain cancer	0.0168	0.0476	CbGbCtD
Amprenavir—CYP3A4—Etoposide—brain cancer	0.0101	0.0285	CbGbCtD
Amprenavir—Opportunistic infection—Temozolomide—brain cancer	0.00168	0.044	CcSEcCtD
Amprenavir—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00161	0.0495	CbGpPWpGaD
Amprenavir—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00148	0.0386	CcSEcCtD
Amprenavir—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00145	0.0445	CbGpPWpGaD
Amprenavir—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00133	0.0407	CbGpPWpGaD
Amprenavir—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00132	0.0405	CbGpPWpGaD
Amprenavir—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00129	0.0397	CbGpPWpGaD
Amprenavir—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00118	0.0361	CbGpPWpGaD
Amprenavir—Transaminases increased—Carmustine—brain cancer	0.00115	0.0301	CcSEcCtD
Amprenavir—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00112	0.0345	CbGpPWpGaD
Amprenavir—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.001	0.0308	CbGpPWpGaD
Amprenavir—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000922	0.0283	CbGpPWpGaD
Amprenavir—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000822	0.0252	CbGpPWpGaD
Amprenavir—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000803	0.0247	CbGpPWpGaD
Amprenavir—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000773	0.0237	CbGpPWpGaD
Amprenavir—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000746	0.0195	CcSEcCtD
Amprenavir—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000696	0.0214	CbGpPWpGaD
Amprenavir—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000669	0.0206	CbGpPWpGaD
Amprenavir—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000621	0.0191	CbGpPWpGaD
Amprenavir—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000612	0.0188	CbGpPWpGaD
Amprenavir—Anorexia—Lomustine—brain cancer	0.000601	0.0157	CcSEcCtD
Amprenavir—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000597	0.0183	CbGpPWpGaD
Amprenavir—Diabetes mellitus—Carmustine—brain cancer	0.000586	0.0153	CcSEcCtD
Amprenavir—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000571	0.0175	CbGpPWpGaD
Amprenavir—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000564	0.0173	CbGpPWpGaD
Amprenavir—Inflammation—Etoposide—brain cancer	0.00056	0.0146	CcSEcCtD
Amprenavir—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000552	0.0169	CbGpPWpGaD
Amprenavir—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000549	0.0169	CbGpPWpGaD
Amprenavir—Decreased appetite—Lomustine—brain cancer	0.000548	0.0143	CcSEcCtD
Amprenavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000538	0.0165	CbGpPWpGaD
Amprenavir—Neutropenia—Hydroxyurea—brain cancer	0.000509	0.0133	CcSEcCtD
Amprenavir—Liver function test abnormal—Carmustine—brain cancer	0.00047	0.0123	CcSEcCtD
Amprenavir—Tremor—Procarbazine—brain cancer	0.00046	0.012	CcSEcCtD
Amprenavir—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000459	0.012	CcSEcCtD
Amprenavir—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000449	0.0138	CbGpPWpGaD
Amprenavir—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000443	0.0116	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000434	0.0113	CcSEcCtD
Amprenavir—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000426	0.0131	CbGpPWpGaD
Amprenavir—Myalgia—Procarbazine—brain cancer	0.000418	0.0109	CcSEcCtD
Amprenavir—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000416	0.0128	CbGpPWpGaD
Amprenavir—Neutropenia—Carmustine—brain cancer	0.000412	0.0108	CcSEcCtD
Amprenavir—Vomiting—Lomustine—brain cancer	0.000401	0.0105	CcSEcCtD
Amprenavir—Neutropenia—Temozolomide—brain cancer	0.000398	0.0104	CcSEcCtD
Amprenavir—Hyperglycaemia—Carmustine—brain cancer	0.000397	0.0104	CcSEcCtD
Amprenavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000396	0.0122	CbGpPWpGaD
Amprenavir—Depression—Carmustine—brain cancer	0.000392	0.0102	CcSEcCtD
Amprenavir—Hyperglycaemia—Temozolomide—brain cancer	0.000384	0.01	CcSEcCtD
Amprenavir—Anorexia—Procarbazine—brain cancer	0.000382	0.00996	CcSEcCtD
Amprenavir—Depression—Temozolomide—brain cancer	0.000378	0.00988	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000376	0.00982	CcSEcCtD
Amprenavir—Nausea—Lomustine—brain cancer	0.000375	0.00978	CcSEcCtD
Amprenavir—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000373	0.0115	CbGpPWpGaD
Amprenavir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000365	0.00952	CcSEcCtD
Amprenavir—Paraesthesia—Procarbazine—brain cancer	0.000359	0.00939	CcSEcCtD
Amprenavir—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000359	0.011	CbGpPWpGaD
Amprenavir—Hepatobiliary disease—Temozolomide—brain cancer	0.000359	0.00937	CcSEcCtD
Amprenavir—Decreased appetite—Procarbazine—brain cancer	0.000348	0.00909	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Etoposide—brain cancer	0.000348	0.00907	CcSEcCtD
Amprenavir—Connective tissue disorder—Carmustine—brain cancer	0.000346	0.00905	CcSEcCtD
Amprenavir—Fatigue—Procarbazine—brain cancer	0.000345	0.00901	CcSEcCtD
Amprenavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000341	0.0105	CbGpPWpGaD
Amprenavir—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000337	0.0103	CbGpPWpGaD
Amprenavir—Connective tissue disorder—Temozolomide—brain cancer	0.000335	0.00874	CcSEcCtD
Amprenavir—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000334	0.0103	CbGpPWpGaD
Amprenavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000334	0.0102	CbGpPWpGaD
Amprenavir—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000329	0.0101	CbGpPWpGaD
Amprenavir—Gastrointestinal pain—Procarbazine—brain cancer	0.000327	0.00855	CcSEcCtD
Amprenavir—Erythema multiforme—Temozolomide—brain cancer	0.000322	0.00841	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000321	0.00838	CcSEcCtD
Amprenavir—Discomfort—Hydroxyurea—brain cancer	0.000319	0.00834	CcSEcCtD
Amprenavir—Neutropenia—Etoposide—brain cancer	0.000318	0.00832	CcSEcCtD
Amprenavir—Abdominal pain—Procarbazine—brain cancer	0.000316	0.00826	CcSEcCtD
Amprenavir—Cardiac disorder—Temozolomide—brain cancer	0.000316	0.00826	CcSEcCtD
Amprenavir—Mental disorder—Carmustine—brain cancer	0.000309	0.00806	CcSEcCtD
Amprenavir—Malnutrition—Carmustine—brain cancer	0.000307	0.00801	CcSEcCtD
Amprenavir—Nervous system disorder—Hydroxyurea—brain cancer	0.000304	0.00793	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000301	0.00786	CcSEcCtD
Amprenavir—Skin disorder—Hydroxyurea—brain cancer	0.000301	0.00786	CcSEcCtD
Amprenavir—Acute coronary syndrome—Etoposide—brain cancer	0.000299	0.00782	CcSEcCtD
Amprenavir—Mental disorder—Temozolomide—brain cancer	0.000298	0.00779	CcSEcCtD
Amprenavir—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000298	0.00917	CbGpPWpGaD
Amprenavir—Myocardial infarction—Etoposide—brain cancer	0.000298	0.00777	CcSEcCtD
Amprenavir—Malnutrition—Temozolomide—brain cancer	0.000297	0.00774	CcSEcCtD
Amprenavir—Anorexia—Hydroxyurea—brain cancer	0.000295	0.00771	CcSEcCtD
Amprenavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000289	0.00888	CbGpPWpGaD
Amprenavir—Tremor—Carmustine—brain cancer	0.000287	0.00751	CcSEcCtD
Amprenavir—Asthenia—Procarbazine—brain cancer	0.000287	0.0075	CcSEcCtD
Amprenavir—Hepatobiliary disease—Etoposide—brain cancer	0.000287	0.0075	CcSEcCtD
Amprenavir—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000285	0.00876	CbGpPWpGaD
Amprenavir—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000283	0.0087	CbGpPWpGaD
Amprenavir—Pruritus—Procarbazine—brain cancer	0.000283	0.0074	CcSEcCtD
Amprenavir—Tremor—Temozolomide—brain cancer	0.000278	0.00726	CcSEcCtD
Amprenavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000277	0.0085	CbGpPWpGaD
Amprenavir—Diarrhoea—Procarbazine—brain cancer	0.000274	0.00715	CcSEcCtD
Amprenavir—Angioedema—Temozolomide—brain cancer	0.000271	0.00708	CcSEcCtD
Amprenavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00027	0.00831	CbGpPWpGaD
Amprenavir—Decreased appetite—Hydroxyurea—brain cancer	0.000269	0.00703	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000267	0.00698	CcSEcCtD
Amprenavir—Fatigue—Hydroxyurea—brain cancer	0.000267	0.00697	CcSEcCtD
Amprenavir—Myalgia—Carmustine—brain cancer	0.000261	0.00682	CcSEcCtD
Amprenavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000258	0.00792	CbGpPWpGaD
Amprenavir—Erythema multiforme—Etoposide—brain cancer	0.000258	0.00673	CcSEcCtD
Amprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000256	0.00788	CbGpPWpGaD
Amprenavir—Vomiting—Procarbazine—brain cancer	0.000255	0.00665	CcSEcCtD
Amprenavir—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000254	0.00782	CbGpPWpGaD
Amprenavir—Cardiac disorder—Etoposide—brain cancer	0.000253	0.00661	CcSEcCtD
Amprenavir—Myalgia—Temozolomide—brain cancer	0.000252	0.00659	CcSEcCtD
Amprenavir—Rash—Procarbazine—brain cancer	0.000252	0.00659	CcSEcCtD
Amprenavir—Dermatitis—Procarbazine—brain cancer	0.000252	0.00658	CcSEcCtD
Amprenavir—Headache—Procarbazine—brain cancer	0.000251	0.00655	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000251	0.00655	CcSEcCtD
Amprenavir—Discomfort—Temozolomide—brain cancer	0.000249	0.00651	CcSEcCtD
Amprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000244	0.0075	CbGpPWpGaD
Amprenavir—Anorexia—Carmustine—brain cancer	0.000239	0.00623	CcSEcCtD
Amprenavir—Nausea—Procarbazine—brain cancer	0.000238	0.00621	CcSEcCtD
Amprenavir—Nervous system disorder—Temozolomide—brain cancer	0.000237	0.0062	CcSEcCtD
Amprenavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000237	0.00729	CbGpPWpGaD
Amprenavir—Skin disorder—Temozolomide—brain cancer	0.000235	0.00614	CcSEcCtD
Amprenavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000234	0.0072	CbGpPWpGaD
Amprenavir—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000234	0.00719	CbGpPWpGaD
Amprenavir—Anorexia—Temozolomide—brain cancer	0.000231	0.00602	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Carmustine—brain cancer	0.000228	0.00596	CcSEcCtD
Amprenavir—Paraesthesia—Carmustine—brain cancer	0.000225	0.00587	CcSEcCtD
Amprenavir—Asthenia—Hydroxyurea—brain cancer	0.000222	0.0058	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00022	0.00576	CcSEcCtD
Amprenavir—Decreased appetite—Carmustine—brain cancer	0.000218	0.00568	CcSEcCtD
Amprenavir—Paraesthesia—Temozolomide—brain cancer	0.000217	0.00567	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Carmustine—brain cancer	0.000216	0.00565	CcSEcCtD
Amprenavir—Diarrhoea—Hydroxyurea—brain cancer	0.000212	0.00554	CcSEcCtD
Amprenavir—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.00021	0.00647	CbGpPWpGaD
Amprenavir—Decreased appetite—Temozolomide—brain cancer	0.00021	0.00549	CcSEcCtD
Amprenavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000209	0.00642	CbGpPWpGaD
Amprenavir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000209	0.00546	CcSEcCtD
Amprenavir—Fatigue—Temozolomide—brain cancer	0.000209	0.00545	CcSEcCtD
Amprenavir—Gastrointestinal pain—Carmustine—brain cancer	0.000205	0.00535	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000201	0.00524	CcSEcCtD
Amprenavir—Discomfort—Etoposide—brain cancer	0.0002	0.00521	CcSEcCtD
Amprenavir—Abdominal pain—Carmustine—brain cancer	0.000198	0.00517	CcSEcCtD
Amprenavir—Gastrointestinal pain—Temozolomide—brain cancer	0.000198	0.00517	CcSEcCtD
Amprenavir—Vomiting—Hydroxyurea—brain cancer	0.000197	0.00514	CcSEcCtD
Amprenavir—Rash—Hydroxyurea—brain cancer	0.000195	0.0051	CcSEcCtD
Amprenavir—Dermatitis—Hydroxyurea—brain cancer	0.000195	0.0051	CcSEcCtD
Amprenavir—Headache—Hydroxyurea—brain cancer	0.000194	0.00507	CcSEcCtD
Amprenavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000192	0.00591	CbGpPWpGaD
Amprenavir—Abdominal pain—Temozolomide—brain cancer	0.000191	0.005	CcSEcCtD
Amprenavir—Skin disorder—Etoposide—brain cancer	0.000188	0.00491	CcSEcCtD
Amprenavir—Anorexia—Etoposide—brain cancer	0.000185	0.00482	CcSEcCtD
Amprenavir—Nausea—Hydroxyurea—brain cancer	0.000184	0.00481	CcSEcCtD
Amprenavir—Asthenia—Carmustine—brain cancer	0.00018	0.00469	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—brain cancer	0.000174	0.00454	CcSEcCtD
Amprenavir—Asthenia—Temozolomide—brain cancer	0.000174	0.00453	CcSEcCtD
Amprenavir—Diarrhoea—Carmustine—brain cancer	0.000171	0.00447	CcSEcCtD
Amprenavir—Pruritus—Temozolomide—brain cancer	0.000171	0.00447	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—brain cancer	0.000168	0.0044	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—brain cancer	0.000167	0.00437	CcSEcCtD
Amprenavir—Fatigue—Etoposide—brain cancer	0.000167	0.00436	CcSEcCtD
Amprenavir—Diarrhoea—Temozolomide—brain cancer	0.000166	0.00432	CcSEcCtD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000162	0.00498	CbGpPWpGaD
Amprenavir—Vomiting—Carmustine—brain cancer	0.000159	0.00416	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—brain cancer	0.000158	0.00414	CcSEcCtD
Amprenavir—Rash—Carmustine—brain cancer	0.000158	0.00412	CcSEcCtD
Amprenavir—Dermatitis—Carmustine—brain cancer	0.000158	0.00412	CcSEcCtD
Amprenavir—Headache—Carmustine—brain cancer	0.000157	0.0041	CcSEcCtD
Amprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000155	0.00476	CbGpPWpGaD
Amprenavir—Vomiting—Temozolomide—brain cancer	0.000154	0.00402	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—brain cancer	0.000153	0.004	CcSEcCtD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000153	0.0047	CbGpPWpGaD
Amprenavir—Rash—Temozolomide—brain cancer	0.000153	0.00398	CcSEcCtD
Amprenavir—Dermatitis—Temozolomide—brain cancer	0.000152	0.00398	CcSEcCtD
Amprenavir—Headache—Temozolomide—brain cancer	0.000152	0.00396	CcSEcCtD
Amprenavir—Nausea—Carmustine—brain cancer	0.000149	0.00388	CcSEcCtD
Amprenavir—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000147	0.00451	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000145	0.00445	CbGpPWpGaD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000145	0.00444	CbGpPWpGaD
Amprenavir—Nausea—Temozolomide—brain cancer	0.000144	0.00375	CcSEcCtD
Amprenavir—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000144	0.00441	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000142	0.00435	CbGpPWpGaD
Amprenavir—Asthenia—Etoposide—brain cancer	0.000139	0.00363	CcSEcCtD
Amprenavir—Pruritus—Etoposide—brain cancer	0.000137	0.00358	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—brain cancer	0.000133	0.00346	CcSEcCtD
Amprenavir—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000132	0.00405	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000126	0.00386	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000124	0.00382	CbGpPWpGaD
Amprenavir—Vomiting—Etoposide—brain cancer	0.000123	0.00322	CcSEcCtD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000123	0.00377	CbGpPWpGaD
Amprenavir—Rash—Etoposide—brain cancer	0.000122	0.00319	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—brain cancer	0.000122	0.00319	CcSEcCtD
Amprenavir—Headache—Etoposide—brain cancer	0.000121	0.00317	CcSEcCtD
Amprenavir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000117	0.00359	CbGpPWpGaD
Amprenavir—Nausea—Etoposide—brain cancer	0.000115	0.003	CcSEcCtD
Amprenavir—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000111	0.00341	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.00011	0.00336	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000102	0.00314	CbGpPWpGaD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000101	0.00311	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000101	0.00309	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	0.0001	0.00308	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.75e-05	0.00269	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.91e-05	0.00212	CbGpPWpGaD
Amprenavir—ABCC1—Disease—DTX2—brain cancer	6.89e-05	0.00212	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.68e-05	0.00205	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.59e-05	0.00202	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.4e-05	0.00197	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.76e-05	0.00177	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.46e-05	0.00168	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HES5—brain cancer	5.06e-05	0.00155	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.78e-05	0.00147	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.78e-05	0.00147	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.64e-05	0.00142	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.61e-05	0.00142	CbGpPWpGaD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.32e-05	0.00133	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.26e-05	0.00131	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP2C9—brain cancer	3.9e-05	0.0012	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.79e-05	0.00116	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—IL2—brain cancer	3.77e-05	0.00116	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.71e-05	0.00114	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.7e-05	0.00114	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.67e-05	0.00113	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.49e-05	0.00107	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.41e-05	0.00105	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IDH1—brain cancer	3.4e-05	0.00105	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—BSG—brain cancer	3.31e-05	0.00102	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.25e-05	0.000998	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HEY1—brain cancer	3.22e-05	0.000991	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.2e-05	0.000984	CbGpPWpGaD
Amprenavir—ABCC1—Disease—DLL1—brain cancer	3.16e-05	0.000972	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.12e-05	0.000958	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—IDH1—brain cancer	2.85e-05	0.000875	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.84e-05	0.000873	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.81e-05	0.000862	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ENO2—brain cancer	2.69e-05	0.000826	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SHH—brain cancer	2.69e-05	0.000826	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.64e-05	0.000812	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP2C9—brain cancer	2.51e-05	0.000772	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP2C9—brain cancer	2.46e-05	0.000755	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.32e-05	0.000713	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ENO2—brain cancer	2.25e-05	0.000692	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.21e-05	0.000678	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—BSG—brain cancer	2.14e-05	0.000656	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2C9—brain cancer	2.13e-05	0.000654	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—BSG—brain cancer	2.09e-05	0.000642	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.05e-05	0.00063	CbGpPWpGaD
Amprenavir—ABCC1—Disease—VAV1—brain cancer	1.94e-05	0.000597	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP2C9—brain cancer	1.9e-05	0.000583	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2C9—brain cancer	1.85e-05	0.000569	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—IDH1—brain cancer	1.84e-05	0.000565	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.81e-05	0.000557	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—BSG—brain cancer	1.81e-05	0.000556	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—IDH1—brain cancer	1.8e-05	0.000552	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.8e-05	0.000552	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2C9—brain cancer	1.75e-05	0.000537	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HES1—brain cancer	1.67e-05	0.000513	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—BSG—brain cancer	1.61e-05	0.000496	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PDGFRA—brain cancer	1.59e-05	0.000489	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.58e-05	0.000486	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—BSG—brain cancer	1.58e-05	0.000484	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—IDH1—brain cancer	1.56e-05	0.000478	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—BSG—brain cancer	1.49e-05	0.000456	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—BSG—brain cancer	1.47e-05	0.000452	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.45e-05	0.000447	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ENO2—brain cancer	1.45e-05	0.000446	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.42e-05	0.000437	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ENO2—brain cancer	1.42e-05	0.000436	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IRS2—brain cancer	1.4e-05	0.000429	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—IDH1—brain cancer	1.39e-05	0.000427	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—IDH1—brain cancer	1.36e-05	0.000416	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—IDH1—brain cancer	1.28e-05	0.000392	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.27e-05	0.000389	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—IDH1—brain cancer	1.27e-05	0.000389	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APC—brain cancer	1.23e-05	0.000379	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ENO2—brain cancer	1.23e-05	0.000378	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.19e-05	0.000367	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2C9—brain cancer	1.14e-05	0.000351	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.13e-05	0.000347	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ENO2—brain cancer	1.1e-05	0.000337	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO2—brain cancer	1.07e-05	0.000329	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CG—brain cancer	1.03e-05	0.000317	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.03e-05	0.000317	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO2—brain cancer	1.01e-05	0.00031	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO2—brain cancer	1e-05	0.000307	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BSG—brain cancer	9.71e-06	0.000298	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—brain cancer	9.58e-06	0.000294	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CTNNB1—brain cancer	8.38e-06	0.000257	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH1—brain cancer	8.35e-06	0.000257	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—brain cancer	7.3e-06	0.000224	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—brain cancer	6.79e-06	0.000209	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CG—brain cancer	6.66e-06	0.000205	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—brain cancer	6.64e-06	0.000204	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO2—brain cancer	6.6e-06	0.000203	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CG—brain cancer	6.51e-06	0.0002	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CG—brain cancer	5.64e-06	0.000173	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CG—brain cancer	5.04e-06	0.000155	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CG—brain cancer	4.91e-06	0.000151	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CG—brain cancer	4.63e-06	0.000142	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CG—brain cancer	4.59e-06	0.000141	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CG—brain cancer	3.03e-06	9.3e-05	CbGpPWpGaD
